|
![]() |
|
|
Medrol: profile and news
Guillen Won't Need Surgery on Wrist Mar 4, 2006 Bobby wakes up on a Sunday Feb 26, 2006 Joint Injections: A Good Idea? 12 Dec 2005 Results Reported in Open-Label Pilot Study of Lidoderm(R) in ... Oct 27, 2005 AAEP Convention 2004 Wrap-Up: Therapeutic Options Jul 26, 2005 NAFDAC Intercepts Fake Products Jun 27, 2005 NAFDAC Intercepts Fake Products 13 Sep 2002 Poison ivy not good for Asselta Jun 2, 2005 Get Lyme disease test as next step Apr 28, 2005 First-Time Generic Approvals: Sandostatin, Dantrium, Grifulvin V ... Apr 13, 2005 SICOR Pharmaceuticals Introduces Methylprednisolone Acetate ... Mar 8, 2005 FDA approves Teva's ANDA for methylprednisolone acetate injectable ... Feb 24, 2005 Market turnaround aids biotech at close Feb 24, 2005 Teva Announces Approval of Methylprednisolone Acetate Injectable ... Feb 24, 2005 AAEP Convention 2004: Controversies in Therapeutics--Mixed Bag of ... Feb 14, 2005 Other information Indication Adjunctive therapy for short-term administration in rheumatoid arthritis. Pharmacology Methylprednisolone and its derivatives, methylprednisolone sodium succinate and methylprednisolone acetate, are synthetic glucocorticoids used as antiinflammatory or immunosuppressive agents. Mechanism Of Action Unbound glucocorticoids cross cell membranes and bind with high affinity to specific cytoplasmic receptors, modifying transcription and protein synthesis. By this mechanism, glucocorticoids can inhibit leukocyte infiltration at the site of inflammation, interfere with mediators of inflammatory response, and suppress humoral immune responses. The antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Drug Category Neuroprotective Agents; Glucocorticoids; Antiemetics; Anti-inflammatory Agents; Adrenergic Agents; ATC:D07AA01; ATC:D07AC14; ATC:D10AA02; ATC:H02AB04 Brand Names/Synonyms 6.Alpha.-Methylprednisolone; 6alpha-Methylprednisolone; A-Methapred; Artisone-Wyeth; BRN 2340300; Besonia; Cortalone; DRG-0050; Delta-Cortef; Depo-Medrol; Dopomedrol; Esametone; Fernisolone-P; Firmacort; HSDB 3127; Lemod; M-Predrol; MEPRDL; Medesone; Medixon; Medlone 21; Medrate; Medrol; Medrol Acetate; Medrol Adt Pak; Medrol Dosepak; Medrone; Mesopren; Metastab; Methyleneprednisolone; Methylprednisolon; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Sodium Succinate; Methylprednisolone, Pharma; Methylprednisolonum [Inn-Latin]; Meti-Derm; Metilbetasone; Metilprednisolona [Inn-Spanish]; Metilprednisolone [Dcit]; Metrisone; Metrocort; Metysolon; Moderin; NSC-19987; Nirypan; Noretona; Predni N Tablinen; Prednisolone; Prednisolone, Methyl-; Prednol- L; Prelone; Promacortine; Reactenol; Sieropresol; Solomet; Solu-Medrol; Sterane; Summicort;; Suprametil; U 7532; Urbason; Urbasone; Wyacort Dosage Forms Tablets, Suspension Absorption Oral bioavailability 80-99% Interactions Interactions for Methylprednisolone: The pharmacokinetic interactions listed below are potentially clinically important. Mutual inhibition of metabolism occurs with concurrent use of cyclosporin and methylprednisolone; therefore, it is possible that adverse events associated with the individual use of either drug may be more apt to occur. convulsions have been reported with concurrent use of methylprednisolone and cyclosporin. Drugs that induce hepatic enzymes such as phenobarbital, phenytoin, and rifampin may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response. Drugs such as troleandomycin and ketoconazole may inhibit the metabolism of methylprednisolone and thus decrease its clearance. Therefore, the dose of methylprednisolone should be titrated to avoid steroid toxicity. Methylprednisolone may increase the clearance of chronic high dose aspirin. This could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when methylprednisolone is withdrawn. Aspirin should be used cautiously in conjunction with corticosteroids in patients suffering from hypoprothrombinemia. The effect of methylprednisolone on oral anticoagulants is variable. There are reports of enhanced as well as diminished effects of anticoagulant when given concurrently with corticosteroids. Therefore, coagulation indices should be monitored to maintain the desired anticoagulant effect. Chemical IUPAC Name 11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical Formula C22H30O5 Half Life 1-3 hours Drug Type Approved Drug # Accession No APRD00342 CAS Registry Number 83-43-2 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |